Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Aug 2022 for 23andMe Holding Co., €16k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Steven J. Schoch: trading record in brief
This profile gathers the share dealings of Steven J. Schoch across 2 companies, led by 23andMe Holding Co. and Arena Pharmaceuticals Inc. Over a trading history stretching from 11 June 2021 to 20 August 2022, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 22 August 2022 came the latest disclosure, a share grant for €16k in 23andMe Holding Co. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven J. Schoch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,782 shares@ US$3.3355.5% of flowClass A Common StockSEC:0001209191-22-047068:0
4,782 shares@ US$2.82100.0% of flowClass A Common StockSEC:0001209191-22-033530:0
4,600 sharesCommon StockSEC:0001628280-22-005911:0
221,227 shares0Class A Common StockSEC:0001209191-22-008893:0
1,533 shares0Common StockSEC:0001628280-21-012276:0
5 of 5 declarations
